Skip to content
DataLookout
Menu

PREVENTNCT07257289

Stratification of Arrhythmic Risk and/or Heart Failure Risk in Patients With Hereditary Heart Disease

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Interventions modified
    • Secondary endpoints: details revised at 1 of 2 entries
    • Study description expanded, about 6 words
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Jan 1, 2036 to Feb 3, 2036
    • Start date changed from estimate of Feb 1, 2026 to Feb 3, 2026
    • Site details revised at 15 of 15 sites
    v3
  3. Notable Start date: Jan 1, 2026 to Feb 1, 2026
    • Eligibility criteria shortened, about 53 words
    • Study sites: 14 to 15
    • Study description expanded, about 7 words
    v2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Arrhythmic and heart failure risk stratification
Timeframe: 5, 8 and 10 years

Secondary (2)

Demographics data
Diagnosis of Brugada syndrome

Arms and interventions

Biologicals: Blood sample

Sites

15 sites in 3 countries

France 13, Martinique 1, Reunion 1